Manufacturer record

Vision Parenteral Pvt. Ltd: regulatory record

Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories

1 batch manufactured by Vision Parenteral Pvt. Ltd were declared Not of Standard Quality between June 2024 and June 2024. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.

Records by type

1 record linked to Vision Parenteral Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.

0Banned or prohibited
0Recalled or suspended
1Failed a lab test
0Regulatory notice
Primary government sourceTier 1: government primary source

CDSCO drug alerts: Not of Standard Quality and spurious drugs

CDSCO · CDSCO monthly NSQ alerts, Jun 2024 to Jun 2024

View original document

Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.

1
NSQ batches since 2024
1
Products affected
Bacterial endotoxins
Most common failure
Jun 2024
Latest alert

Flagged batches per year

2024 · 1

All flagged batches

Product Batch Reason declared NSQ Tested by Alert
Compound Sodium Lactate Injection I.P., 500 ml (Ringer Lactate Solution for Injection) P2401050 08Mfg 2024-01 · Exp 2025-12 Bacterial endotoxinsBacterial endotoxins CDL KolkataCDSCO lab Jun 2024

Batches reported as suspected spurious under this label

CDSCO's spurious-drug alerts list batches that purport to be made by a company but are suspected counterfeits. The labelled manufacturer's reply is shown where CDSCO published it.

ProductBatchReported byFirm's replyAlert
Amoxycillin and Potassium Clavulanate Tablets IP825D167CDL, KolkataThe actual manufacturer (as per label claim) has informed that the impugned batch of the product has not been manufactured by them and that it is a spurious drug.May 2026

Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.